ESMO Immuno-Oncology Congress 2018

Oncology Meeting Resources

13 Dec - 16 Dec 2018, Geneva, Switzerland

ESMO Immuno-Oncology Congress 2018 square

The ESMO Immuno-Oncology Congress helps to increase the overall understanding of the potential of immunotherapy and its implications for clinical practice, today and in the future.

Presentations (slides) and webcasts are available to ESMO members according to the presenters' agreement to release them. Abstracts are open access.
Congress attendees should access via the ESMO Conferences platform .
Resources will be added as they become available.

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme |Future ESMO meetings





Format available

https://oncologypro.esmo.org/Meeting-Resour...omes-for-biomarkers-in-cancer-immune-therapy

Date: 13 Dec 2018
Presenter: Jennifer Wargo
Resources: Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...Asking-T-cells-about-what-they-see-in-cancer

Date: 13 Dec 2018
Presenter: Evan Newell
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour.../Immune-cells-in-the-tumour-microenvironment

Date: 13 Dec 2018
Presenter: Jolanda de Vries
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour...in-the-lung-cancer-combination-therapy-space

Date: 13 Dec 2018
Presenter: Naiyer Rizvi
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour...018/Standard-chemotherapy-A-synergy-with-I-O

Date: 13 Dec 2018
Presenter: Martin Reck
Resources: Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...2018/Radiotherapy-to-boost-the-immune-system

Date: 13 Dec 2018
Presenter: Dirk De Ruysscher
Resources: Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...ion-strategies-in-combination-with-other-I-O

Date: 13 Dec 2018
Presenter: Michel van den Heuvel
Resources: Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...d-modulators-of-the-tumour-micro-environment

Date: 13 Dec 2018
Presenter: George Coukos
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...-lung-cancer-SCLC-Results-from-CheckMate-331

BackgroundDespite high initial response rates, most patients (pts) with SCLC relapse soon after first-line (1L) treatment (tx), with limited tx options and a poor prognosis.

Date: 13 Dec 2018
Presenter: Martin Reck
Resources: Abstract, Presentation, Webcast
Topic: Immunotherapy

https://oncologypro.esmo.org/Meeting-Resour...metastatic-non-small-cell-lung-cancer-MYSTIC

BackgroundDurvalumab (D), a human IgG1 mAb against PD-1 and CD80, has shown clinical activity in patients (pts) with non-small cell lung cancer (NSCLC). Tremelimumab (T) is a human IgG2 mAb against CTLA-4.

Date: 13 Dec 2018
Presenter: Naiyer Rizvi
Resources: Abstract, Presentation, Webcast
Topic: Immunotherapy